Smart tech care for pulmonary embolism patients
Part of Heart & circulation, Lungs & breathing clinical trials.
This study uses smart technology like apps or tablets to help care for people with blood clots in their lungs. It aims to make follow-up easier and more personalized.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 18 or older
- You have a blood clot in your lungs (pulmonary embolism) that was found during this hospital stay, or you have a previous clot that is still there
- You cannot have a long-term clot condition called CTEPH
- You must be able to use a smartphone or tablet
- You cannot be pregnant or breastfeeding
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests if using a smartphone app or tablet helps doctors and patients work together to prevent or manage blood clots in the legs or lungs. It is for adults in the hospital who have or are at high risk of a blood clot.
This trial uses a smart device app to help manage blood clot prevention when you go home from the hospital. It focuses on patients at high risk for clots and uses simple technology to guide their care.
This study looks at a prevention plan to reduce the risk of hospital-acquired blood clots. It may help people who are expected to stay in the hospital for several days but do not already have a clot.
This trial tests a computerized tool that helps doctors decide who needs prevention medicines to lower the risk of blood clots after a hospital stay. It may help reduce preventable clotting risk for people who are less mobile and have added risk factors.
This real-world study compares different treatment approaches for pulmonary embolism (PE)—a serious blood clot in the lung arteries—in patients who are stable but at intermediate-to-high risk of complications. The goal is to understand which treatments work best and safest in everyday practice.
This study tests personalized blood thinner treatments for people with blood clots in their lungs. It looks for patients who are older, have kidney problems, or have cancer, to see if adjusting the treatment helps them more.
Hear when a new Venous Thromboembolism trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.